05/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

05/04/2024

Apr 5, 2024, 08:35 | Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Apr 5, 2024, 08:29 | Drugs
Piotr Wysocki: Promising activity of maintenance olaparib in advanced breast cancer patients responding to platinum-based chemotherapy
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 5, 2024, 08:22 | Insight
Hagop Kantarjian: Low-dose azacitidine plus venetoclax - in patients with AML unable to complete standard consolidation strategies
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas…
Apr 5, 2024, 08:16 | Insight
Oscar Arrieta: Our study shows the impact on overall survival of integrating palliative care early in NSCLC patients
Oscar Arrieta, Head of the Thoracic Oncology Unit at National institute of Oncology in Mexico,…
Apr 5, 2024, 08:10 | Blog
Shikha Jain: Join us at this years WIM Summit in Chicago Sep 13-14
Shikha Jain shared a post on X: "Think this looks like fun? It is! Join…
Apr 5, 2024, 08:01 | Blog
Jordi Remon: In this ASCO Educational Book we summarize EGFR mutated lung cancer
Jordi Remon, Coordinator of the Cancer Medicine Department at CIOCC Barcelona – HM Nou Delfos,…
Apr 5, 2024, 07:53 | Blog
Rafeh Naqash: Couldn’t be more happy to see this project led by the one and only Amin Nassar to be selected for Rapid Oral ASCO24
Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, shared a post on X:…
Apr 5, 2024, 05:05 | Blog
David Fajgenbaum: I had a PET scan to look into my Castleman disease, and the scan came back completely clear
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared a…
Apr 5, 2024, 02:23 | Insight
Piotr J. Wysocki: OPTICAL trial - another study demonstrating the feasibility and promising efficacy of neoadjuvant chemotherapy in locally advanced colon cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 5, 2024, 02:17 | Blog
Gevorg Tamamyan: OncoParty 2024 is on the way and we are honored to have greatest Hosting Committee On May 31st
Gevorg Tamamyan shared on X: “OncoParty 2024 is on the way and we are honored…
All: 46 Posts: 31 - 40